From the microscopic point of view, the major lesions are focal or diffuse chronic inflammatory infiltration, mainly constituted by lynphomononuclear cells, the necrotic degenerative process, and ...

Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and ...

Recent advances have marked a turning point for the treatment noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), with more therapies on the horizon to hopefully better address ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Boehringer Ingelheim has a second positive trial under its belt for nerandomilast in pulmonary fibrosis, setting up regulatory filings. The new data from the 1,178-patient FIBRONEER-ILD study ...

Life with a rare lung disease has been challenging for Diana and her family, but her determination to stay healthy has continued to fuel her spirit.

Data from patients across 3 different randomized controlled trials showed improvements in both adiponectin and PRO-C3, primary end points in the trials.

Teamwork: A Multidisciplinary Approach to Early Lung Cancer: Personalized Care A nurse practitioner with NYU's pulmonary intervention team chronicles the NSCLC patient experience from diagnosis to ...

ARP Atlases. 2007;1:17-47. The total number of leukocytes recovered by lavage is determined by examination of a sample of the pooled fluid with a hemocytometer. The cell counts are most accurate ...

The abnormal accumulation of antibody-producing immune cells in the lungs may contribute to IPF progression, a new study ...

In selected patients long-term success at 6 weeks is approximately 50%. Amiodarone has been shown to be effective in maintaining normal sinus rhythm (NSR), as demonstrated in the AF-CHF trial, in ...